Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38

Go back to Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38
(NASDAQ: GMAB) Delayed: 33.83 +0.54 (1.62%)
Previous Close $33.29    52 Week High
Open $34.04    52 Week Low
Day High $34.50    P/E N/A 
Day Low $33.74    EPS
Volume 538,076       

(NASDAQ: GMAB) Delayed: 33.83 +0.54 (1.62%)
Previous Close $33.29    52 Week High
Open $34.04    52 Week Low
Day High $34.50    P/E N/A 
Day Low $33.74    EPS
Volume 538,076